Description
Recombinant monoclonal antibody to CD64. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma H22. This is a reformatted antibody fragment based on the original Human IgG1 antibody, created for improved compatibility with existing reagents, assays, and techniques.
Target
CD64
Target Alias Names
FcγRI, High affinity immunoglobulin gamma Fc receptor I, IgG Fc receptor I, Fc-gamma RI, FcRI, Fc-gamma RIA
Isotype/Mimetic
Fab fragment
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Methods
Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression

